Interpretation of Hepatitis B Serologic Test Results

Details

• Corporate Authors:
  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis
• Description:
  Hepatitis B serologic testing involves measurement of several hepatitis B virus (HBV)-specific antigens and antibodies. Different serologic “markers” or combinations of markers are used to identify different phases of HBV infection and to determine whether a patient has acute or chronic HBV infection, is immune to HBV as a result of prior infection or vaccination, or is susceptible to infection. Adapted from: A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. Part I: Immunization of Infants, Children, and Adolescents. MMWR 2005; 54 (No. RR-16).
• Subjects:
  Hepatitis B Hepatitis B / Diagnosis Serologic Tests
• Publisher:
  Centers for Disease Control and Prevention (CDC) (U.S.)
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  United States
• Rights:
  Public Domain
• CIO:
  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)
• Division:
  DVH - Division of Viral Hepatitis
• Topic:
  Diseases & Conditions
• Location:
  North America
• Pages in Document:
  1 pdf page
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:9c9ce20f66c8f48cad9ea78dec55b665686a9db73044626c895b6810affb046d907938ddfea2529e017ae399912a07130aebaaaad0cc2c267b1f951ded6e5503
• Download URL:
  https://stacks.cdc.gov/view/cdc/31556/cdc_31556_DS1.pdf
• File Type:
  [PDF - 82.94 KB ]